Wellington Management Group LLP Bristol Myers Squibb CO Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wellington Management Group LLP holds 150,188 shares of BMY stock, worth $8.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

150,188

Previous 166,706 9.91%

Holding current value

$8.38 Million

Previous $6.92 Million 12.26%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $655,103 - $854,806	-16,518 Reduced 9.91%	150,188 $7.77 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $4.84 Million - $6.37 Million	-120,301 Reduced 41.92%	166,706 $6.92 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $13.8 Million - $15.6 Million	287,007 New	287,007 $15.6 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $210 Million - $250 Million	4,322,532 New	4,322,532 $222 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $2.34 Million - $2.62 Million	-40,429 Reduced 0.88%	4,558,404 $265 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $1.88 Million - $2.09 Million	-29,568 Reduced 0.64%	4,598,833 $294 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $282 Million - $320 Million	-4,291,087 Reduced 48.11%	4,628,401 $321 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $1.68 Billion - $1.98 Billion	-24,466,468 Reduced 73.28%	8,919,488 $642 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $308,651 - $182 Million	-2,374,239 Reduced 6.64%	33,385,956 $2.37 Billion
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $491 Million - $541 Million	-6,761,865 Reduced 15.9%	35,760,195 $2.75 Billion
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $469 Million - $562 Million	-7,625,459 Reduced 15.21%	42,522,060 $3.11 Billion
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $254 Million - $296 Million	4,740,155 Added 10.44%	50,147,519 $3.13 Billion
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $85.5 Million - $100 Million	1,444,304 Added 3.29%	45,407,364 $2.69 Billion
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $67.1 Million - $73.1 Million	1,084,441 Added 2.53%	43,963,060 $2.94 Billion
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $170 Million - $191 Million	-2,864,856 Reduced 6.26%	42,878,619 $2.71 Billion
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $476 Million - $539 Million	-8,244,932 Reduced 15.27%	45,743,475 $2.84 Billion
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $555 Million - $615 Million	-9,663,365 Reduced 15.18%	53,988,407 $3.25 Billion
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $650 Million - $760 Million	-11,856,489 Reduced 15.7%	63,651,772 $3.74 Billion
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $369 Million - $537 Million	-7,962,616 Reduced 9.54%	75,508,261 $4.21 Billion
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $4.11 Billion - $5.36 Billion	83,470,877 New	83,470,877 $5.36 Billion

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Bristol Myers Squibb CO Transaction History